Lynda M. Szczech

Nephrology
4419 Ben Franklin Blvd
Durham, NC 27704

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications

Changes in Iron Availability with Roxadustat in Nondialysis- and Dialysis-Dependent Patients with Anemia of CKD.

Changes in Iron Availability with Roxadustat in Nondialysis- and Dialysis-Dependent Patients with Anemia of CKD.

Journal: Kidney360
Published: March 11, 2022

Retraction notice to "Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis." Kidney Int Rep. 2021;6:613-623.

Retraction notice to "Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis." Kidney Int Rep. 2021;6:613-623.

Journal: Kidney international reports
Published: March 08, 2022

A Randomized Trial of Roxadustat in Anemia of Kidney Failure: SIERRAS Study.

A Randomized Trial of Roxadustat in Anemia of Kidney Failure: SIERRAS Study.

Journal: Kidney international reports
Published: December 16, 2020

Roxadustat for CKD-related Anemia in Non-dialysis Patients.

Roxadustat for CKD-related Anemia in Non-dialysis Patients.

Journal: Kidney international reports
Published: November 12, 2020

Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis.

Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis.

Journal: Kidney international reports
Published: November 12, 2020

Efficacy and Cardiovascular Safety of Roxadustat for Treatment of Anemia in Patients with Non-Dialysis-Dependent CKD: Pooled Results of Three Randomized Clinical Trials.

Efficacy and Cardiovascular Safety of Roxadustat for Treatment of Anemia in Patients with Non-Dialysis-Dependent CKD: Pooled Results of Three Randomized Clinical Trials.

Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: October 12, 2020

Roxadustat for anemia in patients with end-stage renal disease incident to dialysis.

Roxadustat for anemia in patients with end-stage renal disease incident to dialysis.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: October 10, 2020

Assessment of dialysis initiation by a fuzzy mathematics equation (ADIFE): a study protocol for a randomised controlled trial.

Assessment of dialysis initiation by a fuzzy mathematics equation (ADIFE): a study protocol for a randomised controlled trial.

Journal: BMJ open
Published: September 11, 2019

Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis.

Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis.

Journal: The New England journal of medicine
Published: July 25, 2019

Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis.

Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis.

Journal: The New England journal of medicine
Published: July 25, 2019

An Equation Based on Fuzzy Mathematics to Assess the Timing of Haemodialysis Initiation.

An Equation Based on Fuzzy Mathematics to Assess the Timing of Haemodialysis Initiation.

Journal: Scientific reports
Published: July 16, 2018

Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China.

Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: October 14, 2016
Showing 1-12 of 53

Last Updated: 09/26/2026